Hello and Welcome to Patientsville.com, Your Source for all ULTIVA information. We are dedicated to provide You with ULTIVA safety information. Learn about ULTIVA serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ULTIVA Safety Reports
Total ULTIVA reports: 4.ULTIVA FDA safety alerts: No.
Reported hospitalizations: 1.
Take ULTIVA Side Effects Survey or Share Your ULTIVA Story. Read More Here.
Consumer or non-health professional from FRANCE reported ULTIVA problem on Apr 04, 2007. Female patient, child 2 years of age, was diagnosed with antibiotic prophylaxis and was treated with ULTIVA. After drug was administered, patient experienced the following problems/side effects: bloody discharge, coagulation time prolonged, international normalised ratio increased, kaolin cephalin clotting time prolonged. ULTIVA dosage: unknown. During the same period patient was treated with AUGMENTIN, KETAMINE, PERFALGAN, HYPNOVEL, MORPHINE, ZOPHREN, NUBAIN. Patient recovered.
ULTIVA problem was reported by a Consumer or non-health professional from FRANCE on Apr 12, 2007. Female patient, child 2 years of age, was diagnosed with antibiotic prophylaxis and was treated with ULTIVA. After drug was administered, patient experienced the following problems/side effects: bloody discharge, coagulation time prolonged, international normalised ratio increased, kaolin cephalin clotting time prolonged. ULTIVA dosage: unknown. During the same period patient was treated with AUGMENTIN, KETAMINE, PERFALGAN, HYPNOVEL, MORPHINE, ZOPHREN, NUBAIN. Patient recovered.
Pharmacist from GERMANY reported ULTIVA problem on June 01, 2007. Male patient, 26 years of age, was diagnosed with nasal septal operation, sedation and was treated with ULTIVA. After drug was administered, patient experienced the following problems/side effects: myoclonus. ULTIVA dosage: unknown. During the same period patient was treated with ATROPINE SULPHATE, PROMETHAZINE, CLINDAMYCIN, RANITIDINE, DORMICUM, ULTRACAIN, DICLOFENAC. Patient was hospitalized. Patient recovered.
ULTIVA problem was reported by a Consumer or non-health professional from FRANCE on Aug 08, 2007. Male patient, 60 years of age, was diagnosed with antibiotic prophylaxis and was treated with ULTIVA. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, hypotension, mechanical ventilation complication, tachycardia. ULTIVA dosage: unknown. During the same period patient was treated with TRACRIUM, AMOXICILLIN AND CLAVULANATE POTASSIUM, DIPRIVAN, SUPRANE. Patient recovered.